Fitness Trends Automated Liquid Handling Systems Market

Automated Liquid Handling Systems Market - Size, Share,
Outlook, and Opportunity Analysis, 2018–2026
Automated liquid handling systems are multipurpose tools designed to perform multiple tasks in
laboratories that include sampling, mixing, and combining of liquid samples automatically. The
automated liquid handling system facilitates elimination of sample contamination and reduces
manual work of lab personnel by performing several laboratory tasks. These workstations are
able to measure samples, add reagents, and ensure addition of liquids to bioassays in uniform
pattern. The liquid handling workstations differ in volume of samples that can be handled and
are available with variety of integrated software to maintain the footprint of the tasks carried
out by these instruments.
Market players are introducing compact and user-friendly liquid handling workstations that can
be operated in small and mid-level laboratories, in order sustain in the competitive market. For
instance, in January 2014, Hamilton Robotics introduced NIMBUS PCR workstation at the
annual Society for Laboratory Automation & Screening Conference. It is a compact and
affordable workstation that enables fast and flexible assay set up. Moreover, Tecan Group
Limited introduced Fluent Gx Automation workstation in February 2018 that is designed
specifically to meet the stringent needs of clinical and regulated laboratories.
Download PDF Brochure Of This Research Report @
https://www.coherentmarketinsights.com/insight/request-pdf/2021
Automated Liquid Handling Systems Market Dynamics
Pharmaceutical companies are increasingly focusing on conducting number of research and
development activities as well as outsourcing such activities to academic and private research
institutes, which is increasing the number of new laboratory set-ups. This in turn increases
demand for liquid handling systems, thereby fostering the market growth. Moreover,
pharmaceutical companies are increasingly outsourcing their research to privately-based contract
research organizations (CRO) to stay competitive in the exponentially growing pharmaceutical
and biotechnology medicines sector. For instance, in May 2018, Ritter Pharmaceuticals, Inc.—a
developer of novel therapeutic products entered into an agreement with Medpace—a clinical